# US 2008/0305474 A1 · Method and Apparatus for Using SLC2A10 Genetic Polymorphisms for Determining Peripheral Vascular Disease in Patients with Type-2 Diabetes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0305474 A1
- Document ID: US20080305474A1
- Status: Published application
- Kind: A1
- Application number: 11/758,862
- Filed: 2007-06-06
- Published: 2008-12-11
- Earliest claimed: 2007-06-06
- Inventors: Yuan-Tsong Chen; Lee-Ming Chuang
- Web page: https://patentgrep.com/patent/US20080305474A1

## CPC

- C12Q 1/6883: for diseases caused by alterations of genetic material
- C12Q 2600/156: Polymorphic or mutational markers
- C12Q 2600/172: Haplotypes
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Recent data indicate that a loss-of-function mutation of the SLC2A10 gene causes arterial tortuosity syndrome (ATS) via upregulation of the TGF-β pathway in the arterial wall, a mechanism possibly causing vascular changes associated with diabetes. It is determined that SLC2A10 (Solute carrier family 2, facilitated glucose transporter, member 10) genetic polymorphism is associated with peripheral vascular disease (PVD) in patients with type 2 diabetes.

## Claims

### Claim 1

A method for determining comprising the step of associating SLC2A10 gene with Peripheral Vascular Disease (PVD) in type-2 diabetic individuals.

### Claim 2 (depends on 1)

The method of claim 1, wherein the SLC2A10 gene comprises a set of relatively common Single Nucleotide Polymorphism (SNP) haplotypes of the SLC2A10 gene.

### Claim 3 (depends on 1)

The method of claim 1, wherein the SLC2A10 gene comprises anyone or all of the fourteen SNPs: rs4810544, rs2425895, rs2143044, rs3092412, rs2235491, rs2425904, rs2425911, rs3091904, rs1059217, rs6066059, rs2179357, rs1003514, rs6018021 or rs6122518.

### Claim 4 (depends on 1)

The method of claim 1, wherein the SLC2A10 gene comprises gene comprises anyone or all of the three SNPs: rs6066059, rs2179357, or rs6122518.
